Boehringer to sell vaccine lines to ElancoOctober 5, 2016Elanco Animal Health plans to acquire more than 40 vaccines from Boehringer Ingelheim Vetmedica Inc. in a transaction valued at $885 million, the companies announced today.
SPONSORED CONTENTBringing Light Home: How Super Pulsed Laser Therapy Enhances Pet HealingOver the past two decades, laser therapy has seen tremendous growth in veterinary practices. What was once considered an alternative therapy is now an integral part of mainstream veterinary care, particularly in rehabilitation, dental, and preventative medicine. +
BIVI's Bordetella vaccine tops 17 million dosesMay 12, 201617 million doses and counting. Boehringer Ingelheim Vetmedica Inc. reported the milestone sales figure Tuesday for Bronchi-Shield Oral, a four-year-old canine Bordetella vaccine.
